We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App

Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel

By LabMedica International staff writers
Posted on 28 Sep 2022
Print article
Image: Mindray ToRCH reagents deliver excellent seroconversion sensitivity (Photo courtesy of Mindray)
Image: Mindray ToRCH reagents deliver excellent seroconversion sensitivity (Photo courtesy of Mindray)

Mindray (Shenzhen, China) has launched the ToRCH Panel that provides high-quality assays to meet different clinical needs. Thanks to the improved raw materials, processes, formulas, reaction models, and standardized traceability, Mindray ToRCH reagents deliver excellent seroconversion sensitivity. Mindray ToRCH has a good detection rate for both samples that are positive in multiple systems and true positive samples such as seroconversion panels. Mindray ToRCH kits support diverse sample types with less quality controls and sample volumes, which ensures great ease and convenience during clinical detection. By bringing the clinical benefits of ToRCH Panel into play and addressing the key requirements for the reagents, Mindray has solved the ToRCH detection challenges facing clinical laboratories and made Mindray ToRCH assays accessible in clinical application.

To achieve high sensitivity and specificity, Mindray has been working consistently to improve the raw materials, processes, formulas, and reaction models. High quality materials are fundamental to ensure high sensitivity and specificity of CLIA assays. To cater to different projects and process requirements, Mindray invested significant resources in the design and development of immunodominant proteins and immunodominant epitopes. Mature, stable and innovative technology is another guarantee of satisfactory performance. For the coating and labeling processes, the Mindray R&D team selected the particles and ALPs that can best meet the assay requirements. To improve the sensitivity and specificity, the Mindray experts spent a considerable amount of time thoroughly studying the parameters using a DOE approach. With a robust design, the boundary of each parameter was determined to ensure the reproducibility of the process.

At the formulation level, the Mindray R&D experts investigated the interference mechanism and classified the interference into four different types to help enhance the anti-interference capacity. Hundreds of commercial and uniquely designed blockers were studied and applied to minimize each type of interference. For instance, the Mindray R&D team designed a capture method for the IgM assay to minimize the interference of IgG and RF (Rheumatoid Factor). The Toxo IgG, CMV IgG and RV IgG quantitative kits of the Mindray ToRCH panel are fabricated with materials with international standard units and the latest standardized traceability. Toxo IgG contains specific IgG and features DT test standardization. CMV IgG adopts the first international standard and features long-term stability. RV IgG comes with a cutoff value of 10 IU/mL as recommended by WHO. The combined examination by Mindray ToRCH IgG and IgM can accurately reveal previous infections and promptly detect ToRCH infections that failed to be ruled out previously.

To demonstrate the sensitivity and specificity of the Mindray ToRCH kits, Mindray conducted tests in over five clinical sites both in and outside China. Although the positive rate varies among different countries and regions, Mindray ToRCH kits have exhibited great specificity for Toxo IgG and ToRCH IgM and excellent sensitivity for RV IgG and CMV IgG. In addition, given the wide coverage of the clinical tests, there are no significant differences between the Chinese and international sites.

Related Links:

Platinum Supplier
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Gold Supplier
Pipette Controller
Sapphire MaxiPette
Respiratory Infections Test
NeoPlex RB-8 Detection Kit

Print article


Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more


view channel
Image: The latest FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer (Photo courtesy of PixCell)

True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

An innovative 5-part differential Complete Blood Count (CBC) analyzer with direct capillary sampling capability significantly simplifies blood sampling and minimizes the pre-analytical process.... Read more


view channel
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)

Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form

The adaptive immune system is an incredible defense mechanism that allows the human body to identify and mount targeted responses against specific pathogens. T-Cells, a special kind of white blood cell,... Read more


view channel
Image: On-chip pretreatment and rapid AST based directly on positive blood cultures (Photo courtesy of Liu Yang)

Integrated Solution for Rapid AST Directly From Positive Blood Cultures to Combat Bloodstream Infection

The presence of living bacteria in the bloodstream, known as bacteremia, can lead to serious conditions like bloodstream infections (BSIs) and sepsis, which can often be fatal. Quickly prescribing the... Read more


view channel
Image: The Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models (Photo courtesy of Gestalt Diagnostics)

New AI Algorithm for Use on Eight Types of Cancer Trained on Seven Scanner Models

A new artificial intelligence (AI) algorithm for use on one of the broadest trained environments is now available for commercial or research work. Gestalt Diagnostics (Spokane, WA, USA) has released the... Read more


view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more


view channel
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.